Work

PISARRO: A EUTROC phase 1b study of APR-246 with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in relapsed platinum-sensitive high grade serous ovarian cancer (HGSOC)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw368.29

Authors: B. Basu, C. Gourley, H. Gabra, I.B. Vergote, J.D. Brenton, L. Abrahmsen, A. Smith, M. Von Euler, J.A. Green

Institutions: University of Cambridge, Institute of Genetics and Cancer, University of Edinburgh, Hammersmith Hospital, Imperial College London, Universitair Ziekenhuis Leuven, Cancer Research UK, OncoGenex Pharmaceuticals (United States), TYDEX, LLC (Russia), University of Liverpool

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587854885

FWCI:

Cites:

Cited by: 8

Related to: 10